What do anti‑streptolysin O (ASO) and anti‑DNase B titers indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What ASO and Anti-DNase B Titers Indicate

ASO and anti-DNase B titers reflect past Group A Streptococcal (GAS) infections, not current acute infections, and are primarily used to confirm recent GAS infection when diagnosing post-streptococcal complications like acute rheumatic fever or post-streptococcal glomerulonephritis 1.

Clinical Utility and Interpretation

When to Use These Tests

These antibody titers are not recommended for diagnosing acute pharyngitis because they indicate immunologic events that have already occurred, not active infection 2. Instead, they serve a specific diagnostic role:

  • Confirming recent GAS infection in patients suspected of having rheumatic fever or glomerulonephritis 1
  • Distinguishing true infection from carrier state in patients with GAS detected in the pharynx 1

Temporal Patterns

The antibodies follow distinct time courses after GAS infection 1:

ASO (Anti-Streptolysin O):

  • Begins rising approximately 1 week after infection
  • Peaks at 3-6 weeks post-infection
  • May remain elevated for several months

Anti-DNase B:

  • Begins rising 1-2 weeks after infection
  • Peaks at 6-8 weeks post-infection
  • May persist for several months

Testing Strategy

Order ASO first; if not elevated, then obtain anti-DNase B 1. The combination of both tests provides maximum sensitivity (95.5%) and specificity (88.6%) for detecting post-streptococcal disease 3. Using both antibodies together is superior to either test alone because:

  • ASO is more sensitive for pharyngeal infections 4
  • Anti-DNase B is more sensitive for skin infections 4
  • Combined testing captures 95.5% of post-streptococcal cases versus 70-73% with single antibody 3

Critical Interpretation Pitfalls

Age-Related Variations

Normal antibody levels are significantly higher in school-age children than adults 1. Misinterpretation commonly occurs when clinicians fail to use age-appropriate reference ranges 1. Recent data shows:

  • Upper limit of normal (80th percentile) for ASO in healthy children can be 346-515 IU/mL depending on age and method 5, 6
  • Peak titers occur in children aged 5-15 years 6

Method-Specific Considerations

Traditional neutralization assays differ from newer latex agglutination or nephelometric methods, which have not been well standardized against traditional assays 1. Use method-specific and population-specific reference ranges when available 5.

Single vs. Paired Samples

A single elevated titer is less reliable than demonstrating a rising titer between acute and convalescent samples 7. When only one measurement is available and timing relative to infection is unknown, interpretation becomes problematic and may lead to misdiagnosis 7.

Clinical Context Matters

Elevated titers confirm recent GAS exposure but do not prove causation of current symptoms. In post-streptococcal disease evaluation:

  • Use titers as supportive evidence alongside clinical criteria
  • Recognize that titers can remain elevated for months after uncomplicated infections 1
  • Consider that healthy children in high-GAS-burden populations may have elevated baseline titers from frequent exposures 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.